Events and
Presentations

August 1, 2018 4:30 PM EDT : Conatus Pharmaceuticals Second Quarter 2018 Financial Results
Open Webcast
August 01

View All

Our
Programs

Emricasan is a first-in-class, orally active caspase inhibitor designed to reduce the activity of ...

Learn More